PS
Psyence Group Inc.
PSYGF · OTC
$0.14 +9.76% (+$0.01)
Market Cap $3.15M
P/E Ratio -
Div. Yield -
ROE 1,575.18%
Bulios Fair Price
$0.13
6.7% downside
Current Price
$0.14
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PSYGF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
42 /100
Fair P/B 4.62x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 21.99%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 145.09%
ROE 1,575.18%
ROA 1,456.90%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 5.95x
Int. coverage -516.51x
Stability
19 /100
Unstable Beta 1.31x
EPS volatility 404.91%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PSYGF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jody Aufrichtig
Employees
0
Headquarters
Toronto